Listed Kenya · PPB

TIVORTIN ASPARTATE ORAL SOLUTION

L-ARGININE ASPARTATE

What it does

Aspartate is used to support various bodily functions and may be included in treatments for certain conditions.

Commonly used for: supporting metabolism, improving energy levels

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Hard to find? We help patients in Kenya source rare medicines. We don't sell or dispense medicines - licensed pharmacies do.

Source this medicine

Registration & product details

Registration no.
CTD 2881
Registration date
-
Expiry date
-
Status
Unknown
Active ingredient
L-ARGININE ASPARTATE
Strength
-
Pack size
100 ML AND 200 ML POLYMER VIALS. 1 VIAL IN A CARTON.
Therapeutic class
GENERIC/BIOSIMILARS
RxNorm RxCUI
42543
Manufacturer / MAH
Harleys
Applicant / LTR
YURIA PHARMA
Country of origin
FOREIGN

Source: Pharmacy and Poisons Board · fetched 2026-01-28 20:11:04 · updated 2026-09-06 02:02:51

Disclaimer: This information is sourced from Pharmacy and Poisons Board (Kenya). Always consult a qualified healthcare professional before using any medication.

About this medicine

Aspartate is used to support various bodily functions and may be included in treatments for certain conditions.

What it treats

  • supporting metabolism
  • improving energy levels

How it works

Aspartate helps in the production of energy in the body by participating in metabolic processes.

Who it's for

Aspartate is generally for individuals needing support in energy production and metabolic health.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: aspartate

BNF-referenced

Aspartate, specifically L-aspartate, is a non-essential amino acid that plays a critical role in various metabolic processes in the body. It is synthesized from oxaloacetate through transamination and is involved in the synthesis of proteins, nucleic acids, and other biomolecules. Its ergogenic claims suggest potential benefits in enhancing exercise performance and recovery, although these effects require further validation.

Indications

  • Supplemental support for exercise performance
  • Potential aid in reducing fatigue during physical exertion

Dosage

Children: Refer to the BNF for Children for specific paediatric dosing information.

Adults: Refer to the BNF for specific dosing recommendations.

Mechanism of action

L-aspartate is hypothesized to enhance performance in prolonged and short intensive exercise by sparing muscle glycogen stores and promoting glycogen resynthesis. It serves as a substrate for energy production in the Krebs cycle and stimulates the purine nucleotide cycle, thus potentially influencing energy metabolism during physical activity.

Pharmacodynamics

As a non-essential amino acid, L-aspartate is produced in sufficient quantities under normal physiological conditions. It is a precursor for protein synthesis and plays a role in various metabolic pathways, including those related to energy production and nucleotide synthesis. It is classified as a glycogenic amino acid, contributing to gluconeogenesis and energy metabolism.

Pharmacokinetics

L-aspartate is readily absorbed and utilized by the body, participating in several metabolic pathways, including the Krebs cycle and amino acid metabolism. The exact pharmacokinetic parameters such as half-life, peak plasma concentration, and elimination route are not well characterized in the literature.

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Molecular reference: aspartate

PubChem CID 5960

Molecular formula: C4H7NO4

Mechanism of action

There are also claims that L-aspartate has ergogenic effects, that it enhances performance in both prolonged exercise and short intensive exercise. It is hypothesized that L-aspartate, especially the potassium magnesium aspartate salt, spares stores of muscle glycogen and/or promotes a faster rate of glycogen resynthesis during exercise. It has also been hypothesized that L-aspartate can enhance short intensive exercise by serving as a substrate for energy production in the Krebs cycle and for stimulating the purine nucleotide cycle.

Pharmacodynamics

L-aspartate is considered a non-essential amino acid, meaning that, under normal physiological conditions, sufficient amounts of the amino acid are synthesized in the body to meet the body's requirements. L-aspartate is formed by the transamination of the Krebs cycle intermediate oxaloacetate. The amino acid serves as a precursor for synthesis of proteins, oligopeptides, purines, pyrimidines, nucleic acids and L-arginine. L-aspartate is a glycogenic amino acid, and it can also promote energy production via its metabolism in the Krebs cycle. These latter activities were the rationale for the claim that supplemental aspartate has an anti-fatigue effect on skeletal muscle, a claim that was never confirmed.

Source: PubChem (NCBI) · pathways from PathBank, Reactome, WikiPathways & PharmGKB.

This drug in other countries

The same active ingredient registered across other registries we cover - including different brands.